Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

The Donut or the Hole? Prioritizing Patient and Caregiver Values in the Delivery of High-Quality Medical Management Without Dialysis.

Saeed F, Lupu D, Moss AH.

Am J Kidney Dis. 2019 Feb;73(2):153-155. doi: 10.1053/j.ajkd.2018.10.003. Epub 2018 Dec 10. No abstract available.

PMID:
30545706
2.
3.

Fluoxetine Affects Differentiation of Midbrain Dopaminergic Neurons In Vitro.

Lupu D, Varshney MK, Mucs D, Inzunza J, Norinder U, Loghin F, Nalvarte I, Rüegg J.

Mol Pharmacol. 2018 Oct;94(4):1220-1231. doi: 10.1124/mol.118.112342. Epub 2018 Aug 16.

PMID:
30115672
4.

Methylmercury interferes with glucocorticoid receptor: Potential role in the mediation of developmental neurotoxicity.

Spulber S, Raciti M, Dulko-Smith B, Lupu D, Rüegg J, Nam K, Ceccatelli S.

Toxicol Appl Pharmacol. 2018 Sep 1;354:94-100. doi: 10.1016/j.taap.2018.02.021. Epub 2018 Feb 28.

PMID:
29499248
5.

Estrogenic and anti-estrogenic activity of butylparaben, butylated hydroxyanisole, butylated hydroxytoluene and propyl gallate and their binary mixtures on two estrogen responsive cell lines (T47D-Kbluc, MCF-7).

Pop A, Drugan T, Gutleb AC, Lupu D, Cherfan J, Loghin F, Kiss B.

J Appl Toxicol. 2018 Jul;38(7):944-957. doi: 10.1002/jat.3601. Epub 2018 Feb 19.

PMID:
29460325
6.

The Growing Demand for Hospice and Palliative Medicine Physicians: Will the Supply Keep Up?

Lupu D, Quigley L, Mehfoud N, Salsberg ES.

J Pain Symptom Manage. 2018 Apr;55(4):1216-1223. doi: 10.1016/j.jpainsymman.2018.01.011. Epub 2018 Feb 2.

PMID:
29410071
7.

Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory.

Gardner SA, Weymouth KS, Kelly WS, Bogdanova E, Chen W, Lupu D, Suhl J, Zeng Q, Geigenmüller U, Boles D, Okamoto PM, McDowell G, Hayden MA, Nagan N.

Hered Cancer Clin Pract. 2018 Jan 4;16:1. doi: 10.1186/s13053-017-0083-8. eCollection 2018.

8.

Fluoxetine modulates sex steroid levels in vitro.

Lupu D, Sjödin MOD, Varshney M, Lindberg J, Loghin F, Rüegg J.

Clujul Med. 2017;90(4):420-424. doi: 10.15386/cjmed-868. Epub 2017 Oct 20.

9.

Role of estrogen receptor beta in neural differentiation of mouse embryonic stem cells.

Varshney MK, Inzunza J, Lupu D, Ganapathy V, Antonson P, Rüegg J, Nalvarte I, Gustafsson JÅ.

Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10428-E10437. doi: 10.1073/pnas.1714094114. Epub 2017 Nov 13.

10.

The 2015 Class of Hospice and Palliative Medicine Fellows-From Training to Practice: Implications for HPM Workforce Supply.

Lupu D, Salsberg E, Quigley L, Wu X.

J Pain Symptom Manage. 2017 May;53(5):944-951. doi: 10.1016/j.jpainsymman.2017.01.005. Epub 2017 Feb 9.

PMID:
28189768
11.

Altered methylation of specific DNA loci in the liver of Bhmt-null mice results in repression of Iqgap2 and F2rl2 and is associated with development of preneoplastic foci.

Lupu DS, Orozco LD, Wang Y, Cullen JM, Pellegrini M, Zeisel SH.

FASEB J. 2017 May;31(5):2090-2103. doi: 10.1096/fj.201601169R. Epub 2017 Feb 8.

12.

Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement.

Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, Broder MS, Shapiro CL, Acheson AK, Malin J, Evans T, Krzyzanowska MK.

J Oncol Pract. 2016 Sep;12(9):e828-38. doi: 10.1200/JOP.2016.010686. Epub 2016 Aug 16.

PMID:
27531376
13.

Providing supportive care to patients with kidney disease.

Russell JS, Lupu D, Seliger S, Moss AH.

Nephrol News Issues. 2016 May;30(5):28, 30, 32 passim.

PMID:
27382864
14.

Individual and combined in vitro (anti)androgenic effects of certain food additives and cosmetic preservatives.

Pop A, Drugan T, Gutleb AC, Lupu D, Cherfan J, Loghin F, Kiss B.

Toxicol In Vitro. 2016 Apr;32:269-77. doi: 10.1016/j.tiv.2016.01.012. Epub 2016 Jan 23.

PMID:
26812027
15.

Unmet Supportive Care Needs in U.S. Dialysis Centers and Lack of Knowledge of Available Resources to Address Them.

Culp S, Lupu D, Arenella C, Armistead N, Moss AH.

J Pain Symptom Manage. 2016 Apr;51(4):756-761.e2. doi: 10.1016/j.jpainsymman.2015.11.017. Epub 2015 Dec 17.

PMID:
26706629
16.

In vitro modulation of estrogen receptor activity by norfluoxetine.

Lupu D, Pop A, Cherfan J, Kiss B, Loghin F.

Clujul Med. 2015;88(3):386-90. doi: 10.15386/cjmed-476. Epub 2015 Jul 1.

17.

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors.

Pop A, Lupu DI, Cherfan J, Kiss B, Loghin F.

Clujul Med. 2015;88(3):381-5. doi: 10.15386/cjmed-474. Epub 2015 Jul 1.

18.

End-Stage Kidney Disease Without Dialysis.

Moss AH, Armistead N, Lupu D.

Health Aff (Millwood). 2015 Nov;34(11):2005. doi: 10.1377/hlthaff.2015.1225. No abstract available.

PMID:
26526269
19.

Genetic and epigenetic transgenerational implications related to omega-3 fatty acids. Part II: maternal FADS2 rs174575 genotype and DNA methylation predict toddler cognitive performance.

Cheatham CL, Lupu DS, Niculescu MD.

Nutr Res. 2015 Nov;35(11):948-55. doi: 10.1016/j.nutres.2015.09.005. Epub 2015 Sep 11.

PMID:
26455892
20.
21.

Measuring what matters: top-ranked quality indicators for hospice and palliative care from the American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association.

Dy SM, Kiley KB, Ast K, Lupu D, Norton SA, McMillan SC, Herr K, Rotella JD, Casarett DJ.

J Pain Symptom Manage. 2015 Apr;49(4):773-81. doi: 10.1016/j.jpainsymman.2015.01.012. Epub 2015 Feb 16.

PMID:
25697097
22.

Hospice innovation impediments: can halfway efforts tame the terrible choice?

Lupu DE, Ivanko B, Insana F, White PH, Arnold RM.

J Palliat Med. 2014 Oct;17(10):1088-90. doi: 10.1089/jpm.2014.0268. Epub 2014 Sep 16. No abstract available.

PMID:
25225847
23.

The quality imperative for palliative care.

Kamal AH, Hanson LC, Casarett DJ, Dy SM, Pantilat SZ, Lupu D, Abernethy AP.

J Pain Symptom Manage. 2015 Feb;49(2):243-53. doi: 10.1016/j.jpainsymman.2014.06.008. Epub 2014 Jul 22.

24.
25.

Few U.S. public health schools offer courses on palliative and end-of-life care policy.

Lupu D, Deneszczuk C, Leystra T, McKinnon R, Seng V.

J Palliat Med. 2013 Dec;16(12):1582-7. doi: 10.1089/jpm.2013.0161. Epub 2013 Nov 20.

26.

Perinatal epigenetic determinants of cognitive and metabolic disorders.

Lupu DS, Tint D, Niculescu MD.

Aging Dis. 2012 Dec;3(6):444-53. Epub 2012 Sep 27.

27.

Perinatal manipulation of α-linolenic acid intake induces epigenetic changes in maternal and offspring livers.

Niculescu MD, Lupu DS, Craciunescu CN.

FASEB J. 2013 Jan;27(1):350-8. doi: 10.1096/fj.12-210724. Epub 2012 Sep 20.

PMID:
22997227
28.

Progress towards systems of quality measurement that capture the essence of good palliative care.

Dy SM, Lupu D, Seow H.

Palliat Med. 2012 Jun;26(4):291-3. doi: 10.1177/0269216312444796. No abstract available.

PMID:
22585596
29.

Foreword: quality improvement efforts: advancing the science of palliative care.

Casarett DJ, Dy S, Spence C, Lupu D.

J Pain Symptom Manage. 2011 Nov;42(5):649-51. doi: 10.1016/j.jpainsymman.2011.08.001. No abstract available.

PMID:
22045366
30.

Maternal α-linolenic acid availability during gestation and lactation alters the postnatal hippocampal development in the mouse offspring.

Niculescu MD, Lupu DS, Craciunescu CN.

Int J Dev Neurosci. 2011 Dec;29(8):795-802. doi: 10.1016/j.ijdevneu.2011.09.006. Epub 2011 Sep 28.

31.

Estimate of current hospice and palliative medicine physician workforce shortage.

Lupu D; American Academy of Hospice and Palliative Medicine Workforce Task Force.

J Pain Symptom Manage. 2010 Dec;40(6):899-911. doi: 10.1016/j.jpainsymman.2010.07.004.

PMID:
21145468
32.

Nutritional influence on epigenetics and effects on longevity.

Niculescu MD, Lupu DS.

Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):35-40. doi: 10.1097/MCO.0b013e328340ff7c. Review.

PMID:
21088573
33.

The kidney in cirrhosis with portal hypertension.

Olteanu D, Lupu D.

J Med Life. 2010 Apr-Jun;3(2):175-7. Review.

34.

AAHPM position paper: requirements for the successful development of academic palliative care programs.

Bruera E, Billings JA, Lupu D, Ritchie CS; Academic Palliative Medicine Task Force of the American Academy of Hospice and Palliative Medicine.

J Pain Symptom Manage. 2010 Apr;39(4):743-55. doi: 10.1016/j.jpainsymman.2010.02.001. No abstract available.

PMID:
20413061
35.

High fat diet-induced maternal obesity alters fetal hippocampal development.

Niculescu MD, Lupu DS.

Int J Dev Neurosci. 2009 Nov;27(7):627-33. doi: 10.1016/j.ijdevneu.2009.08.005. Epub 2009 Aug 18.

36.

Effects of the Fe-Co interaction on the growth of multiwall carbon nanotubes.

Li Z, Dervishi E, Xu Y, Ma X, Saini V, Biris AS, Little R, Biris AR, Lupu D.

J Chem Phys. 2008 Aug 21;129(7):074712. doi: 10.1063/1.2971180.

PMID:
19044797
37.

The influence of the newly formed hospice and palliative medicine subspecialty on radiation oncology and end-of-life care.

Lutz S, Lupu D, Johnstone P, Howell DD, Janjan N.

J Am Coll Radiol. 2008 Nov;5(11):1102-5. doi: 10.1016/j.jacr.2008.06.015. No abstract available.

PMID:
18954807
38.

Cobalt nanoparticles coated with graphitic shells as localized radio frequency absorbers for cancer therapy.

Xu Y, Mahmood M, Li Z, Dervishi E, Trigwell S, Zharov VP, Ali N, Saini V, Biris AR, Lupu D, Boldor D, Biris AS.

Nanotechnology. 2008 Oct 29;19(43):435102. doi: 10.1088/0957-4484/19/43/435102. Epub 2008 Sep 22.

PMID:
21832683
39.

Preparing for the hospice and palliative medicine certification examination.

Lupu DE, Davis LG, Weir S.

J Palliat Med. 2008 Jul;11(6):814-5. doi: 10.1089/jpm.2008.9887. No abstract available.

PMID:
18715166
40.

Investigation of carbon nanofibers as support for bioactive substances.

Olenic L, Mihailescu G, Pruneanu S, Lupu D, Biris AR, Margineanu P, Garabagiu S, Biris AS.

J Mater Sci Mater Med. 2009 Jan;20(1):177-83. doi: 10.1007/s10856-008-3550-y. Epub 2008 Aug 16.

PMID:
18709446
41.

CO2 enhanced carbon nanotube synthesis from pyrolysis of hydrocarbons.

Li Z, Xu Y, Ma X, Dervishi E, Saini V, Biris AR, Lupu D, Biris AS.

Chem Commun (Camb). 2008 Jul 28;(28):3260-2. doi: 10.1039/b803465f. Epub 2008 May 23.

PMID:
18622437
42.

Comparative study on different carbon nanotube materials in terms of transparent conductive coatings.

Li Z, Kandel HR, Dervishi E, Saini V, Xu Y, Biris AR, Lupu D, Salamo GJ, Biris AS.

Langmuir. 2008 Mar 18;24(6):2655-62. doi: 10.1021/la701880h. Epub 2008 Feb 6.

PMID:
18251555
43.

Influence of impurities on the x-ray photoelectron spectroscopy and Raman spectra of single-wall carbon nanotubes.

Li Z, Biris AS, Dervishi E, Saini V, Xu Y, Biris AR, Lupu D.

J Chem Phys. 2007 Oct 21;127(15):154713.

PMID:
17949197
44.

Formal ABMS and ACGME recognition of hospice and palliative medicine expected in 2006.

Portenoy RK, Lupu DE, Arnold RM, Cordes A, Storey P.

J Palliat Med. 2006 Feb;9(1):21-3. No abstract available.

PMID:
16430340
45.

Misconception about hospice.

Portenoy R, Lupu D.

Health Aff (Millwood). 2005 Nov-Dec;24(6):1686; author reply 1687-8. No abstract available.

PMID:
16284049
46.

Progress for palliative medicine as a subspecialty.

von Gunten CF, Lupu D.

J Support Oncol. 2005 Jul-Aug;3(4):267-8. No abstract available.

PMID:
16092596
47.

The road to formal recognition: the end is in sight.

Portenoy RK, Lupu D, Arnold RM, Cordes A, Storey P.

J Palliat Med. 2005 Apr;8(2):266-8. No abstract available.

PMID:
15890035
48.

Extrahepatic manifestations in hepatitis C virus infection.

Olteanu D, Argeşanu M, Radu L, Nestor D, Brătănescu S, Lupu D.

Rom J Intern Med. 2004;42(1):69-81. Review.

PMID:
15529596
49.

Recognizing palliative medicine as a subspecialty: what does it mean for oncology?

von Gunten CF, Lupu D.

J Support Oncol. 2004 Mar-Apr;2(2):166-74. Review. No abstract available.

PMID:
15328819
50.

Development of a medical subspecialty in palliative medicine: progress report.

von Gunten CF, Lupu D.

J Palliat Med. 2004 Apr;7(2):209-19.

PMID:
15130199

Supplemental Content

Support Center